Delphine Vimont
Ingénieur d'étude
IE / ADERA/ Contact
Publications
-
Theranostics of Primary Prostate Cancer: Beyond PSMA and GRP-R
Cancers. 2023-04-18. 15(8) : 2345.
10.3390/cancers15082345 -
Design, Synthesis, and Biological Evaluation of the First Radio-Metalated Neurotensin Analogue Targeting Neurotensin Receptor 2
ACS Omega. 2023-02-10. 8(7) : 6994-7004.
10.1021/acsomega.2c07814 -
Comparison of 68Ga-PSMA-617 PET/CT and 68Ga-RM2 PET/CT in patients with localized prostate cancer candidate for radical prostatectomy: a prospective, single arm, single center, phase II study
J Nucl Med. 2022-09-02. : jnumed.122.263889.
10.2967/jnumed.122.263889 -
In vitro and pilot in vivo imaging of 18 kDa translocator protein (TSPO) in inflammatory vascular disease.
EJNMMI Res. 2021-05-05. 11(1)
10.1186/s13550-021-00786-7 -
Silicon-Containing Neurotensin Analogues as Radiopharmaceuticals for NTS1-Positive Tumors Imaging
Bioconjugate Chem.. 2020-09-18.
10.1021/acs.bioconjchem.0c00419 -
Design, synthesis, and biological evaluation of a multifunctional neuropeptide-Y conjugate for selective nuclear delivery of radiolanthanides
EJNMMI Res. 2020-03-02. 10(1)
10.1186/s13550-020-0612-8 -
Comparison of the radiolabeled PSMA-inhibitor 111In-PSMA-617 and the radiolabeled GRP-R antagonist 111In-RM2 in primary prostate cancer samples
EJNMMI Res. 2019-06-03. 9(1)
10.1186/s13550-019-0517-6